NFE2L2 and chronic myelogenous leukemia, BCR-ABL1 positive: Further work to delineate which mechanism of NF-κB inactivation by Wogonin for inhibition of transcription of Nrf2 offers the possibility of paving the way for the development of combination therapies more effective in the treatment of CML.